Effects of Omega-3 Fatty Acids on Markers of Inflammation

NCT01129050 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2023-02-22

No results posted yet for this study

Summary

The major purpose of this study is to examine the effect of two sources of dietary omega-3 fatty acids, each given at two doses, on potential health benefits related to cardiovascular disease prevention. The two sources of dietary omega-3 fatty acids will be fish oil, and flaxseed oil.

Conditions

Interventions

DIETARY_SUPPLEMENT

Fish Oil

Fish oil capsule

DIETARY_SUPPLEMENT

Flaxseed Oil

Flaxseed oil capsule

DIETARY_SUPPLEMENT

Placebo

Soybean oil capsule

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH
  • Stanford University

    lead OTHER

Principal Investigators

  • Christopher D Gardner · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01129050 on ClinicalTrials.gov